| Literature DB >> 27626828 |
Stinne W Hansen1, Mette N Erichsen1, Bingru Fu1, Walden E Bjørn-Yoshimoto1, Bjarke Abrahamsen1, Jacob C Hansen1, Anders A Jensen1, Lennart Bunch1.
Abstract
Screening of a small compound library at the three excitatory amino acid transporter subtypes 1-3 (EAAT1-3) resulted in the identification of compound (Z)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid (1a) that exhibited a distinct preference as an inhibitor at EAAT1 (IC50 20 μM) compared to EAAT2 and EAAT3 (IC50 > 300 μM). This prompted us to subject 1a to an elaborate structure-activity relationship study through the purchase and synthesis and subsequent pharmacological characterization of a total of 36 analogues. Although this effort did not result in analogues with substantially improved inhibitory potencies at EAAT1 compared to that displayed by the hit, it provided a detailed insight into structural requirements for EAAT1 activity of this scaffold. The discovery of this new class of EAAT1-selective inhibitors not only supplements the currently available pharmacological tools in the EAAT field but also substantiates the notion that EAAT ligands not derived from α-amino acids hold considerable potential in terms of subtype-selective modulation of the transporters.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27626828 DOI: 10.1021/acs.jmedchem.6b01058
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446